WIT (WIT) Stock Price & Analysis
WIT (WIT) fell 0.92% to USD 2.16 as of June 9, 2026 at 23:36 UTC, according to Nexqual real-time market data.
WIT last closed at USD 2.18; the session ranged USD 2.13–2.23 on volume of 10,646,811 shares. Market capitalization is $22.66B, with a 52-week range of USD 1.8–3.13 (NYQ). Source: Nexqual, June 9, 2026 at 23:36 UTC.
Key Statistics (as of June 9, 2026 at 23:36 UTC)
| Price | USD 2.16 |
|---|---|
| Change | ▼ 0.92% (down) |
| Previous Close | USD 2.18 |
| Open | USD 2.14 |
| Day Range | USD 2.13 – 2.23 |
| 52-Week Range | USD 1.8 – 3.13 |
| Volume | 10,646,811 shares |
| Market Cap | $22.66B |
| Exchange | NYQ |
Technical Analysis (WIT)
Nexqual's technical model rates WIT "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 9, 2026 at 23:36 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 52.85 (neutral) |
| vs SMA50 | Above (USD 2.09) |
| MACD | 0.04 (positive) |
Analyst Ratings (WIT)
Wall Street analysts rate WIT "Underperform" based on 7 analysts, with a mean price target of USD 2.09 (range USD 1.8–2.3), per Nexqual as of June 9, 2026 at 23:36 UTC.
| Consensus Rating | Underperform |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 2.09 |
| High Target | USD 2.3 |
| Low Target | USD 1.8 |
| Buy / Hold / Sell | 0 / 3 / 4 |
Earnings (WIT)
| Next Earnings Date | 2026-07-16 |
|---|---|
| EPS Estimate | USD 0.04 |
| Revenue Estimate | $241.37B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.04 vs est 0.04 ▼ miss |
| 2025-12-31 | USD 0.04 vs est 0.04 ▼ miss |
| 2025-09-30 | USD 0.04 vs est 0.04 ▼ miss |
| 2025-06-30 | USD 0.04 vs est 0.04 ▲ beat |
Source: Nexqual, June 9, 2026 at 23:36 UTC.
Financials & Fundamentals (WIT)
| Total Revenue | $926.24B |
|---|---|
| Revenue Growth (YoY) | +7.70% |
| Gross Margin | +29.15% |
| Operating Margin | +17.18% |
| Profit Margin | +14.25% |
| ROE | +15.44% |
| Debt / Equity | 22.85 |
| Current Ratio | 2.05 |
| Total Cash | $543.24B |
| Total Debt | $202.91B |
| Free Cash Flow | $115.36B |
Source: Nexqual, June 9, 2026 at 23:36 UTC.
Financial Health Score (WIT)
Nexqual rates WIT's overall financial health "Solid" across five dimensions, as of June 9, 2026 at 23:36 UTC.
| Growth | Mixed — Revenue +4.0% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 29%, operating 17% |
| Balance Sheet | Strong — $543.2B cash vs $202.9B debt, net cash position |
| Cash Flow | Solid — FCF $115.4B, 12% margin |
| Efficiency | Solid — ROE 15%, ROA 6.9% |
Ownership (WIT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +3.52% |
| Shares Outstanding | 10.49B |
| Float | 3.05B |
| Short % of Float | +3.09% |
Source: Nexqual, June 9, 2026 at 23:36 UTC.
Leadership (WIT)
WIT is led by Srinivas Pallia (age 58), CEO, MD, Executive Director & Member of Executive Board, per Nexqual as of June 9, 2026 at 23:36 UTC.
| CEO, MD, Executive Director & Member of Executive Board | Srinivas Pallia (age 58) |
|---|---|
| Executive Chairman | Rishad Azim Hasham Premji (age 48) |
| Senior VP, CFO & Member of Executive Board | Aparna C. Iyer (age 43) |
| Chief Operating Officer | Sanjeev Jain |
Major Backers & Investors (WIT)
Notable institutional backers of WIT include Morgan Stanley, First Trust Advisors LP, First TRT Exch-Trd Fd.-First TRT Value Line Dividend Index Fd., according to Nexqual as of June 9, 2026 at 23:36 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 0.44% |
| First Trust Advisors LP | 0.2% |
| First TRT Exch-Trd Fd.-First TRT Value Line Dividend Index Fd. | 0.15% |
| Penserra Capital Management LLC | 0.14% |
| Defiance Etfs, LLC | 0.14% |
| ETF Series Solutions-Defiance Quantum ETF | 0.14% |
| Avantyr Capital Partners, LP | 0.13% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.59% |
| Vanguard Group | 0.4% |
| State Street | 0.29% |
Source: Nexqual, June 9, 2026 at 23:36 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INFY | Infosys Limited | USD 12.24 | ▼ 1.29% |
| IBN | ICICI Bank Limited | USD 26.29 | ▲ 1.31% |
| SAY | Saratoga Investment Corp 8.125% | USD 25.26 | ▼ 0.37% |
| RDY | Dr. Reddy's Laboratories Ltd | USD 13.37 | ▲ 0.98% |
| HDB | HDFC Bank Limited | USD 23.29 | ▼ 0.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:36 UTC. This page is informational and not investment advice.